Author:
Geiger M.,Janes T.,Keshavarz H.,Summers S.,Pinger C.,Fletcher D.,Zinn K.,Tennakoon M.,Karunarathne A.,Spence D.
Abstract
AbstractPeople with type 1 diabetes (T1D) require exogenous administration of insulin, which stimulates the translocation of the GLUT4 glucose transporter to cell membranes. However, most bloodstream cells contain GLUT1 and are not directly affected by insulin. Here, we report that C-peptide, the 31-amino acid peptide secreted in equal amounts with insulin in vivo, is part of a 3-component complex that affects red blood cell (RBC) membranes. Multiple techniques were used to demonstrate saturable and specific C-peptide binding to RBCs when delivered as part of a complex with albumin. Importantly, when the complex also included Zn2+, a significant increase in cell membrane GLUT1 was measured, thus providing a cellular effect similar to insulin, but on a transporter on which insulin has no effect.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Publisher
Springer Science and Business Media LLC
Reference49 articles.
1. Rosenfeld, L. Insulin: discovery and controversy. Clin. Chem. 48, 2270–2288 (2002).
2. Brostoff, J. M., Keen, H. & Brostoff, J. A diabetic life before and after the insulin era. Diabetologia 50, 1351–1353 (2007).
3. Allen, F. M., Stillman, E., Fitz R. Monographs of the Rockefeller Institute for Medical Research. (The Rockefeller Institute for Medical Research, 1919).
4. Huo, L., Harding, J. L., Peeters, A., Shaw, J. E. & Magliano, D. J. Life expectancy of type 1 diabetic patients during 1997–2010: a national Australian registry-based cohort study. Diabetologia 59, 1177–1185 (2016).
5. Forbes, J. M. & Cooper, M. E. Mechanisms of diabetic complications. Physiol. Rev. 93, 137–188 (2013).
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献